Word

EDINIMAGE

Status

Dead

Status Code

710

Status Date

Friday, March 29, 2024

Serial Number

86934417

Registration Number

5288675

Registration Date

Tuesday, September 19, 2017

Mark Type

4000

Filing Date

Wednesday, March 9, 2016

Published for Opposition

Tuesday, July 4, 2017

Cancellation Date

Friday, March 29, 2024

Trademark Owner History

Edinburgh Molecular Imaging Ltd - Original Registrant

Classifications

9 Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking, supervision, life-saving and teaching apparatus and instruments, namely, medical laboratory research instruments for detecting pathogens, thermal imaging, DNA analysis; apparatus for recording, transmission or reproduction of sound or images; blank magnetic data carriers, blank optical recording discs; blank recordable CD-Rs, DVDs and USB flash drives; imaging apparatus, namely, microscopes; laser equipment for non-medical purposes, namely, laser microprobe for obtaining information on molecular structure of matter; electronic measuring apparatus and instruments, namely, microspectrophotometers; imaging instruments, namely, microscopes; scientific apparatus and instruments, namely, ultra-high vacuum chambers and parts thereof; data processing equipment; computer software for processing and displaying images on medical imaging machines; computer software for medical imaging equipment, namely, for interpreting and analysing the results of medical tests and CT scanners; computer application software for mobile phones, namely, software for processing and displaying images on medical imaging machines; computer application software for mobile phones, namely, software for interpreting and analysing the results of medical tests and CT scanners; downloadable electronic publications in the nature of reports and case studies in the field of molecular sciences and the detection, diagnosis, and treatment of diseases

5 Pharmaceutical preparations for the treatment of cancer; contrast media for use in medical imaging; contrast media for in vivo imaging; contrasting agents for diagnostic ultrasound imaging; contrast media for use with imaging medical equipment, namely, contrast agents and chemicals for use in modifying the spectral or luminescent properties of other materials for medical use; contrast media for use with imaging medical equipment in the nature of luminescent chemicals for use as a luminescent label; biomolecule labelling kits comprising primarily diagnostic reagents for medicinal use for use in colorimetric or luminescent labelling; gases and gas mixtures for medical imaging use; diagnostic scanning agents for medical use; diagnostic reagents for medical use in the field of cancer; reagents for the detection and diagnosis of infections and diseases; diagnostic reagent kits comprising primarily of diagnostic reagents for medical use in the field of cancer; chemical reagents for medical use

1 Chemical agents in the nature of contrast agents for use in molecular imaging and not for medical use; chemicals for use in molecular separation processes for use in industry and science, other than medical and veterinary use; chemical reagents for non-medical purposes for use in molecular imaging; contrast agents and chemicals for non-medical purposes for use in modifying the spectral or luminescent properties of other materials; luminescent chemicals for industrial purposes; fluorescent chemicals for industrial purposes; luminescent chemicals for industrial purposes for use as a luminescent label; fluorescent chemicals for industrial purposes for use as a fluorescent label; fluorogenic chemicals for industrial purposes; colorimetric chemicals for industrial purposes; biomolecule labelling kits comprising primarily reagents for non-medical use in colorimetric or luminescent labelling; diagnostic reagents for scientific or research use in the field of cancer; diagnostic reagents for scientific research relating to molecular identification and digital quantification; diagnostic reagent kits comprising primarily diagnostic reagents for scientific or research use in the field of cancer

44 Medical services, namely, services for medical analysis; medical imaging services; human healthcare services; medical services for the diagnosis of conditions of the human body; information, consultancy and advisory services relating to all of the aforesaid services

10 urological imaging systems

42 Scientific and technological services, namely, scientific research, analysis, testing in the field of molecular sciences and the detection, diagnosis, and treatment of diseases; chemical research and analysis services; research relating to molecular sciences; analysis in the field of molecular biology; research and analysis in the field of molecular imaging and chemical reagents; scientific research for medical purposes in the area of cancerous diseases; information, consultancy and advisory services relating to all of the aforesaid services

Trademark Events

Mar 29, 2024

Cancelled Sec. 8 (6-Yr)

Sep 19, 2022

Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed

Sep 19, 2017

Registered-Principal Register

Jul 4, 2017

Official Gazette Publication Confirmation E-Mailed

Jul 4, 2017

Published For Opposition

Jun 14, 2017

Notification Of Notice Of Publication E-Mailed

May 30, 2017

Law Office Publication Review Completed

May 18, 2017

Approved For Pub - Principal Register

May 18, 2017

Examiner's Amendment Entered

May 18, 2017

Notification Of Examiners Amendment E-Mailed

May 18, 2017

Examiners Amendment E-Mailed

May 18, 2017

Examiners Amendment -Written

May 17, 2017

Teas/Email Correspondence Entered

May 16, 2017

Correspondence Received In Law Office

May 16, 2017

Teas Response To Office Action Received

Jan 5, 2017

Notification Of Non-Final Action E-Mailed

Jan 5, 2017

Non-Final Action E-Mailed

Jan 5, 2017

Non-Final Action Written

Oct 31, 2016

Teas/Email Correspondence Entered

Oct 31, 2016

Correspondence Received In Law Office

Oct 27, 2016

Assigned To Lie

Oct 19, 2016

Teas Response To Office Action Received

Jun 30, 2016

Notification Of Non-Final Action E-Mailed

Jun 30, 2016

Non-Final Action E-Mailed

Jun 30, 2016

Non-Final Action Written

Jun 21, 2016

Assigned To Examiner

Mar 14, 2016

New Application Office Supplied Data Entered

Mar 12, 2016

New Application Entered